Stay updated on Nivolumab Plus Ipilimumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in Melanoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T09:55:52.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A notice about NIH websites transitioning from the term “Artificial Intelligence” to “Super Intelligence” appears above the ClinicalTrials.gov page. The study record remains inaccessible with a 403 error.
    Difference
    1%
    Check dated 2026-10-24T10:30:13.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.1 to v3.7.2 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-17T12:18:46.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-10T12:17:23.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden message, replacing the previous study record content. The header shows minimal navigation and a footer with revision information, indicating a restricted or error state.
    Difference
    17%
    Check dated 2026-09-19T19:15:16.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Removed related topics entries for Melanoma and MedlinePlus Genetics from the page. This changes the available topic links without altering the primary study details.
    Difference
    0.1%
    Check dated 2026-09-05T19:18:17.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Melanoma Clinical Trial page.